Iceland vs Montenegro: Tuberculosis patients living with HIV receiving antiretroviral therapy
Iceland
0 patients
in 2014
Montenegro
0 patients
in 2021
Iceland rank
141st
Montenegro rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Iceland
- Montenegro
How they compare
Iceland currently reports 0 patients against 0 patients in Montenegro, a difference of 0 patients.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Iceland ahead.
Iceland ranks 141st and Montenegro ranks 141st of 183 countries.
Across the 2 decades both report, Iceland averaged higher in 1 and Montenegro in 1.
Head to head by decade
| Decade | Iceland | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.5 patients | 0.25 patients | 0.25 patients | Iceland |
| 2010s | 0 patients | 0.6 patients | 0.6 patients | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Iceland or Montenegro?
- Iceland, at 0 patients against 0 patients in Montenegro as of 2014.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Iceland and Montenegro?
- 0 patients, with Iceland ahead.
- How many years of comparable data are there for Iceland and Montenegro?
- 9 years are reported by both, from 2005 to 2014.
- How do Iceland and Montenegro rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Iceland ranks 141st and Montenegro ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.